Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients
NCT ID: NCT02642874
Last Updated: 2018-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
200 participants
INTERVENTIONAL
2017-04-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis
NCT02221570
Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis
NCT02423395
Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients
NCT04509336
Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis
NCT05724485
Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled Trial
NCT03892070
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Methocarbamol
Methocarbamol twice daily
Methocarbamol
Methocarbamol twice daily
placebo
Calcium carbonate twice daily
Calcium Carbonate
Calcium carbonate twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methocarbamol
Methocarbamol twice daily
Calcium Carbonate
Calcium carbonate twice daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Encephalopathy
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Consultant liver and GIT diseases- Tanta university hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sherief M. Abd-Elsalam, Consultant
Role: PRINCIPAL_INVESTIGATOR
liver diseases dept.- Tanta university hospital
Walaa A. Elkhalawany, Consultant
Role: STUDY_DIRECTOR
liver diseases dept.- Tanta university hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta university - faculty of medicine
Tanta, Elgharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
methocarbamol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.